John Wiley & Sons(US:WLY)2025-12-05 14:40Revenue Performance - For the three months ended October 31, 2025, consolidated revenue decreased by $4.8 million, or 1%, compared to the prior year, with Adjusted Revenue of $421.8 million[150][151]. - Research revenue increased by $16.6 million, or 6%, to $278,514 million for the three months ended October 31, 2025, driven by growth in Research Publishing[185]. - Learning revenue decreased by $18.3 million, or 11%, to $143,237 million for the same period, attributed to market-related softness and a decline in print sales[189]. - Revenue for the six months ended October 31, 2025 decreased by $11.9 million, or 1%, compared to the prior year, with a constant currency decrease of 2%[196]. - Research revenue for the six months ended October 31, 2025, increased by $33 million, or 6%, compared to the prior year, with Research Solutions revenue growing by 18%[227]. - Learning revenue decreased by $27.5 million, or 10%, for the six months ended October 31, 2025, compared to the prior year, primarily due to declines in print sales and license revenue[231]. Income and Earnings - Operating income for the same period increased by $8.9 million, or 14%, to $73.0 million, driven by lower operating and administrative expenses[155][164]. - Adjusted EBITDA for the three months ended October 31, 2025, was $115.1 million, reflecting an 8% increase compared to the prior year[155][166]. - US GAAP Income Before Taxes was $58,010 million, an increase from $48,937 million in the same period of 2024, representing a growth of 20%[177]. - Non-GAAP Adjusted Income Before Taxes for the same period was $78,596 million, up from $69,141 million in 2024, reflecting a 14% increase[177]. - Diluted earnings per share increased to $0.84 for the three months ended October 31, 2025, compared to $0.74 in 2024, marking a 14% rise[182]. - Diluted Earnings per Share rose to $1.05 for the six months ended October 31, 2025, up from $0.71 in 2024, marking an increase of 48.6%[224]. Expenses and Cost Management - Operating and administrative expenses decreased by $13.8 million, or 6%, to $225.1 million, primarily due to restructuring and cost savings initiatives[154]. - Operating and administrative expenses decreased by $22.3 million, or 5%, to $465.4 million for the six months ended October 31, 2025[201]. - Interest expense decreased to $11.7 million for the three months ended October 31, 2025, down from $14.5 million in the prior year[169]. - Interest expense decreased to $22.7 million for the six months ended October 31, 2025, down from $27.3 million in the prior year[213]. - The company recorded restructuring and related charges of $6.0 million for the three months ended October 31, 2025, compared to $3.6 million in the prior year[156]. AI and Research Segment - Artificial intelligence (AI) license revenue increased to $6.0 million for the three months ended October 31, 2025, up from $4.0 million in the prior year[150]. - Research AI license revenue reached $4.8 million for the three months ended October 31, 2025, compared to none in the prior year[186]. - AI license revenue increased to $34.9 million for the six months ended October 31, 2025, up from $21 million in the prior year, including $15.7 million from licensed content[196]. - Research AI license revenue surged to $20.7 million for the six months ended October 31, 2025, compared to approximately $1 million in the prior year[228]. - Adjusted EBITDA for the Research segment increased by 14% to $93,280 million on a constant currency basis, driven by higher revenue[187]. - Adjusted Operating Income for the Research segment increased by 18% to $69,961 million for the three months ended October 31, 2025[184]. Tax and Financial Position - The US GAAP Effective Tax Rate increased to 22.6% for the three months ended October 31, 2025, compared to 17.3% in 2024, primarily due to a change in jurisdictional mix of earnings[178]. - The US GAAP Effective Tax Rate decreased to 25.3% for the six months ended October 31, 2025, down from 45.8% in 2024, mainly due to a change in jurisdictional mix of earnings[222]. - The company maintains a strong liquidity position, with operating cash flow and credit facilities expected to meet operational and investment needs over the next twelve months[238]. - As of October 31, 2025, the company had cash and cash equivalents of $67.4 million, with approximately 95% located outside the US[239]. - The company reported approximately $871.7 million of debt outstanding as of October 31, 2025, with $423.5 million of unused borrowing capacity under its Amended and Restated Credit Agreement[241]. Cash Flow and Dividends - For the six months ended October 31, 2025, net cash used in operating activities was $(76.5) million, an improvement from $(94.0) million in the same period of 2024[243]. - Free cash flow less product development spending for the six months ended October 31, 2025 was $(107.9) million, compared to $(130.1) million in the prior year[245]. - Net cash provided by investing activities for the six months ended October 31, 2025 was $72.4 million, a significant increase from net cash used of $(44.5) million in the prior year[252]. - Net cash used in financing activities was $(13.0) million for the six months ended October 31, 2025, compared to net cash provided of $113.1 million in the same period of 2024[253]. - The company increased its quarterly dividend to shareholders to $1.42 per share annualized, up from $1.41 per share in the prior year[254]. Foreign Exchange and Other - Net foreign exchange transaction gains were $1.0 million for the three months ended October 31, 2025, compared to losses of $(3.3) million in the prior year[170][171]. - The company recorded foreign currency translation losses of approximately $(10.0) million for the six months ended October 31, 2025, primarily due to fluctuations in the US dollar relative to the British pound sterling[263]. - Other expense, net was $(2.1) million for the six months ended October 31, 2025, compared to other income, net of $3.0 million in the prior year[220].